Chief Scientific Officer · SUTRO BIOPHARMA, INC. (STRO)

Trevor Hallam

A named executive officer of SUTRO BIOPHARMA in every fiscal year CompBrief holds from FY2017 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,421,083

Salary $488,333Stock awards $1,355,650

FY2020: $1,241,270

3rd of 5 named executive officers at Sutro Biopharma by FY2021 total.

5 named officers on file for SUTRO BIOPHARMA, FY2021

Trevor Hallam’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • STRO’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how SUTRO BIOPHARMA’s whole pay program stands against its peers

  • SUTRO BIOPHARMA’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on STRO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2022 (DEF 14A).

Free

Get Trevor Hallam’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Trevor Hallam compensation by year

SUTRO BIOPHARMA Summary Compensation Table · all 5 fiscal years held
In US dollars, as SUTRO BIOPHARMA reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021
Salary$393,975$405,800$418,000$430,500$488,333
Bonus$0$0$0——
Stock awards$0$702,465$0$211,890$1,355,650
Option awards$0$2,951,998$330,600$268,850$1,182,600
Non-equity incentive$134,000$202,900$150,480$198,030$262,500
Pension and deferred compensation$0$0$0$0$0
All other$149,951$132,000$132,000$132,000$132,000
Total$677,926$4,395,163$1,031,080$1,241,270$3,421,083

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SUTRO BIOPHARMA, INC. DEF 14A filed April 25, 2022, accession 0000950170-22-006031, and prior-year filings. Open the filing on EDGAR.

How this page was built: the SUTRO BIOPHARMA, INC. filed document, accession 0000950170-22-006031. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2022.

$678K
$4.4M
$1.0M
$1.2M
$3.4M
FY17
FY18
FY19
FY20
FY21
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU50,000$1,055,500—
RSU15,000$300,150—
RSU15,750$158,918—
Option40,737—$21.11
Option6,666—$15.00
Option11,875—$10.45
Option990—$10.45
Option8,013—$21.11
Option15,626—$20.01
Option9,875—$10.09
Option14,865—$10.09
Option30,525—$15.00

Per the Outstanding Equity Awards at Fiscal Year-End table in SUTRO BIOPHARMA, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 13 award rows shown.

SUTRO BIOPHARMA’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
William NewellChief Executive Officer$5,633,678
RPh Jane ChungChief Commercial Officer$4,253,474
Trevor Hallam · this pageChief Scientific Officer$3,421,083
Arturo MolinaM.S., FACP, Chief Medical Officer$2,645,527
Edward AlbiniChief Financial Officer$2,083,750

The full SUTRO BIOPHARMA compensation record

free company brief

This page is one person within SUTRO BIOPHARMA's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the SUTRO BIOPHARMA proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are SUTRO BIOPHARMA's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Trevor Hallam's compensation dossier · One-time report. No refunds.